Journal of Diabetes and Its Complications
Volume 23, Issue 3 , Pages 209-213 , May 2009

The effects of sulfonylurea glyburide on superoxide dismutase, catalase, and glutathione peroxidase activities in the brain tissue of streptozotocin-induced diabetic rat

Received 3 July 2007 ,Revised 6 August 2007 ,Accepted 6 September 2007.

References 

  1. Aebi H. Catalase in vitro. Methods in Enzymology. 1984;105:121–126
  2. Altan N, Altan VM, Mikolay L, Larner J, Schwartz CF. Insulin-like and insulin-enhancing effects of the sulfonylurea glyburide on rat adipose glycogen synthase. Diabetes. 1985;34(3):281–286
  3. Altan N, Ongun CO, Hasanoğlu E, Engin A, Tuncer C, Sindel P. Effects of the sulfonylurea glyburide on superoxide dismutase activity in alloxan-induced diabetic rat hepatocytes. Diabetic Research and Clinical Practice. 1994;22:95–98
  4. Atalay T, Altan N, Ongun CO, Alagol H. Effect of the sulfonylurea glyburide on glycogen synthesis in alloxan-induced diabetic rat hepatocytes. General Pharmacology. 1994;25(7):1435–1437
  5. Baynes JW, Thrope SR. Role of oxidative stress in diabetic complications. Diabetes. 1999;48:1–9
  6. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Archives of Biochemistry and Biophysics. 1985;240(2):500–508
  7. Bukan N, Sancak B, Bilgihan A, Kosova F, Bugdayci G, Altan N. The effects of the sulfonylurea glyburide on glutathione peroxidase, superoxide dismutase and catalase activities in the heart tissue of streptozotocin-induced diabetic rat. Methods and Findings in Experimental and Clinical Pharmacology. 2004;26(7):519–522
  8. Bukan N, Sancak B, Yavuz O, Koca C, Tutkun F, Ozcelikay AT, et al. Lipid peroxidation and scavenging enzyme levels in the liver of streptozotocin-induced diabetic rats. Indian Journal of Biochemistry and Biophysics. 2003;40:447–450
  9. Cakatay A, Telci R, Kayali F, Tekili T, Akcay T, Sivas A. Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain. Experimental Gerontology. 2001;36:221–229
  10. Carney JM, Strake-Reed PE, Oliver CN, Landum RW, Chang MS, Wu JF, et al. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity and loss in temporal and spatial memory by chronic administration of the spin trapping compound N-tert-buty-alfa-pheynitrone. Proceedings of the National Academy of Sciences of the United States of America. 1991;88:3633–3636
  11. Cerutti PA. Oxy-radicals and cancer. Lancet. 1994;344:862–863
  12. Danh HC, Benedetti MS, Dostert P. Differential changes in superoxide dismutase activity in brain and liver of old rats and mice. Journal of Neurochemistry. 1983;40(4):1003–1007
  13. Elmalı E, Altan N, Bukan N. Effect of sulphonylurea glibenclamide on liver and kidney antioxidant enzymes in streptozotocin-induced diabetic rats. Drugs in R&D. 2004;5(4):203–208
  14. Feldman JM, Lebovitz HE. An insulin-dependent effect of chronic tolbutamid administration on the skeletal muscle carbohydrate transport system. Diabetes. 1969;18:84–95
  15. Halliwell B. Role of free radicals in the neurodegenerative diseases. Therapeutic implication for antioxidative treatment. Drug & Aging. 2001;18:685–716
  16. Heikkila RE, Cabbat F. A sensitive assay for superoxide dismutase based on the autoxidation of 6-hydroxydopamine. Analytical Biochemistry. 1976;75:356–362
  17. Jain SK, Levine SN. Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats. Free Radical Biology & Medicine. 1995;18(2):337–341
  18. Jeng CY, Hollenbeck CB, Wu MS, et al. How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes?. Diabetic Medicine. 1989;6(4):303–308
  19. Joost HG, Arend W, Hold SA. Effects of tolbutamid on insulin binding to isolated fat cells of the rat. Biochemical Pharmacology. 1982;31:1227–1231
  20. Kawai N, Keep RP, Betz AL, Nagao S. Hyperglycemia induces progressive changes in the cerebral microvasculature and blood–brain barrier transport during focal cerebral ischemia. Acta Neurochirurgica. 1998;71(Suppl Weir):219–221
  21. Kumar JS, Menon VP. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism. 1993;42(8):1435–1439
  22. Leelavinothan P, Muniappan L. Protective role of Scoparia dulcis plant extract on brain antioxidant status and lipid peroxidation in STZ diabetic male Wistar rats. BMC Complementary and Alternative Medicine. 2004;2:4–16
  23. Li PA, Gisselsson J, Keuker J, Vogel ML, Kuschinsky SW, Siesjo K. Hyperglycemia-exaggerated ischemic brain damage following 30 min of middle cerebral artery occlusion is not due to capillary obstruction. Brain Research. 1998;804:36–44
  24. Loven D, Scheldi H, Wilson H, Daabees TT, Stegink LD, Diekus M, et al. Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozotocin-induced diabetes. Diabetes. 1986;35:503–507
  25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 1951;193:265
  26. Luzi L, Poza G. Glibenclamide: An old drug with a novel mechanism of action?. Acta Diabetologica. 1997;34(4):239–244
  27. McCall AL. The impact of diabetes on the CNS. Diabetes. 1992;41:557–570
  28. Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase and Cu/Zn SOD for cell survival against oxidative stress. Free Radical Biology & Medicine. 1994;17(3):235–248
  29. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte GPx. Journal of Laboratory and Clinical Medicine. 1976;70:158–169
  30. Rafaelson OJ. Action of oral antidiabetic drugs on carbohydrate metabolism of isolated rat diaphragm. Metabolism. 1959;8:195–204
  31. Robertson RP, Harmon J, Tran PO, et al. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53(Suppl. 1):119–124
  32. Salchonick AI, Konowitz P, Amatruda JM. Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats. Diabetes. 1983;32:206–212
  33. Simonson DC, Ferrannini E, Bevilacqua S, et al. Mechanisms of improvement in glucose metabolism after chronic glyburide therapy. Diabetes. 1984;33(9):838–845
  34. Sindhu RK, Koo JR, Roberts CK, Vaziri ND. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: Response to insulin and antioxidant therapies. Clinical and Experimental Hypertension. 2004;26(1):43–53
  35. Southorn PA, Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clinic Proceedings. 1988;63:390–408
  36. Tilton RG, Chang K, Nyengaard JR, Vandenenden M, Ido Y, Williamson JR. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats. Diabetes. 1995;44:234–242
  37. Toleikis PM, Godin DV. Alteration of antioxidant status in diabetic rats by chronic exposure to psychological stressors, pharmacology biochemistry and behavior. Pharmacology, Biochemistry and Behavior. 1995;52(2):355–366
  38. Traystman RJ, Kırsch RJ, Koehler RC. Oxygen radical mechanism of brain injury following ischemia and reperfusion. Journal of Applied Physiology. 1991;71(4):1185–1191
  39. Tuzun S, Girgin FK, Sozmen EY, Mentes G, Ersoz B. Antioxidant status in experimental type 2 diabetes mellitus: Effects of glibenclamide and glipizide on various rat tissues. Experimental and Toxicologic Pathology. 1999;51:436–441
  40. Wolff SP. Diabetes mellitus and free radicals: Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. British Medical Bulletin. 1993;49(3):642–652

PII: S1056-8727(07)00107-9

doi: 10.1016/j.jdiacomp.2007.09.001

Journal of Diabetes and Its Complications
Volume 23, Issue 3 , Pages 209-213 , May 2009

Article Tools